Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Service Type Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Behavioral Health Market
5.1. COVID-19 Landscape: Behavioral Health Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Behavioral Health Market, By Service Type
8.1. Behavioral Health Market, by Service Type, 2024-2033
8.1.1 Home-Based Treatment Services
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Outpatient Counselling
8.1.2.1. Market Revenue and Forecast (2021-2033)
8.1.3. Emergency Mental Health Services
8.1.3.1. Market Revenue and Forecast (2021-2033)
8.1.4. Inpatient Hospital Treatment
8.1.4.1. Market Revenue and Forecast (2021-2033)
8.1.5. Intensive Care Management
8.1.5.1. Market Revenue and Forecast (2021-2033)
Chapter 9. Global Behavioral Health Market, By Disorder Type
9.1. Behavioral Health Market, by Disorder Type, 2024-2033
9.1.1. Bipolar Disorder
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Anxiety Disorder
9.1.2.1. Market Revenue and Forecast (2021-2033)
9.1.3. Depression
9.1.3.1. Market Revenue and Forecast (2021-2033)
9.1.4. Post-Traumatic Stress Disorder
9.1.4.1. Market Revenue and Forecast (2021-2033)
9.1.5. Eating Disorder
9.1.5.1. Market Revenue and Forecast (2021-2033)
9.1.6. Substance Abuse Disorder
9.1.6.1. Market Revenue and Forecast (2021-2033)
9.1.7. Others
9.1.7.1. Market Revenue and Forecast (2021-2033)
Chapter 10. Global Behavioral Health Market, By End-Users
10.1. Behavioral Health Market, by End-Users, 2024-2033
10.1.1. Outpatient Clinics
10.1.1.1. Market Revenue and Forecast (2021-2033)
10.1.2. Hospitals
10.1.2.1. Market Revenue and Forecast (2021-2033)
10.1.3. Rehabilitation Centers
10.1.3.1. Market Revenue and Forecast (2021-2033)
10.1.4. Homecare Setting
10.1.4.1. Market Revenue and Forecast (2021-2033)
Chapter 11. Global Behavioral Health Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Service Type (2021-2033)
11.1.2. Market Revenue and Forecast, by Disorder Type (2021-2033)
11.1.3. Market Revenue and Forecast, by End-Users (2021-2033)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Service Type (2021-2033)
11.1.4.2. Market Revenue and Forecast, by Disorder Type (2021-2033)
11.1.4.3. Market Revenue and Forecast, by End-Users (2021-2033)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Service Type (2021-2033)
11.1.5.2. Market Revenue and Forecast, by Disorder Type (2021-2033)
11.1.5.3. Market Revenue and Forecast, by End-Users (2021-2033)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Service Type (2021-2033)
11.2.2. Market Revenue and Forecast, by Disorder Type (2021-2033)
11.2.3. Market Revenue and Forecast, by End-Users (2021-2033)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Service Type (2021-2033)
11.2.4.2. Market Revenue and Forecast, by Disorder Type (2021-2033)
11.2.4.3. Market Revenue and Forecast, by End-Users (2021-2033)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Service Type (2021-2033)
11.2.5.2. Market Revenue and Forecast, by Disorder Type (2021-2033)
11.2.5.3. Market Revenue and Forecast, by End-Users (2021-2033)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Service Type (2021-2033)
11.2.6.2. Market Revenue and Forecast, by Disorder Type (2021-2033)
11.2.6.3. Market Revenue and Forecast, by End-Users (2021-2033)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Service Type (2021-2033)
11.2.7.2. Market Revenue and Forecast, by Disorder Type (2021-2033)
11.2.7.3. Market Revenue and Forecast, by End-Users (2021-2033)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Service Type (2021-2033)
11.3.2. Market Revenue and Forecast, by Disorder Type (2021-2033)
11.3.3. Market Revenue and Forecast, by End-Users (2021-2033)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Service Type (2021-2033)
11.3.4.2. Market Revenue and Forecast, by Disorder Type (2021-2033)
11.3.4.3. Market Revenue and Forecast, by End-Users (2021-2033)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Service Type (2021-2033)
11.3.5.2. Market Revenue and Forecast, by Disorder Type (2021-2033)
11.3.5.3. Market Revenue and Forecast, by End-Users (2021-2033)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Service Type (2021-2033)
11.3.6.2. Market Revenue and Forecast, by Disorder Type (2021-2033)
11.3.6.3. Market Revenue and Forecast, by End-Users (2021-2033)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Service Type (2021-2033)
11.3.7.2. Market Revenue and Forecast, by Disorder Type (2021-2033)
11.3.7.3. Market Revenue and Forecast, by End-Users (2021-2033)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Service Type (2021-2033)
11.4.2. Market Revenue and Forecast, by Disorder Type (2021-2033)
11.4.3. Market Revenue and Forecast, by End-Users (2021-2033)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Service Type (2021-2033)
11.4.4.2. Market Revenue and Forecast, by Disorder Type (2021-2033)
11.4.4.3. Market Revenue and Forecast, by End-Users (2021-2033)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Service Type (2021-2033)
11.4.5.2. Market Revenue and Forecast, by Disorder Type (2021-2033)
11.4.5.3. Market Revenue and Forecast, by End-Users (2021-2033)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Service Type (2021-2033)
11.4.6.2. Market Revenue and Forecast, by Disorder Type (2021-2033)
11.4.6.3. Market Revenue and Forecast, by End-Users (2021-2033)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Service Type (2021-2033)
11.4.7.2. Market Revenue and Forecast, by Disorder Type (2021-2033)
11.4.7.3. Market Revenue and Forecast, by End-Users (2021-2033)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Service Type (2021-2033)
11.5.2. Market Revenue and Forecast, by Disorder Type (2021-2033)
11.5.3. Market Revenue and Forecast, by End-Users (2021-2033)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Service Type (2021-2033)
11.5.4.2. Market Revenue and Forecast, by Disorder Type (2021-2033)
11.5.4.3. Market Revenue and Forecast, by End-Users (2021-2033)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Service Type (2021-2033)
11.5.5.2. Market Revenue and Forecast, by Disorder Type (2021-2033)
11.5.5.3. Market Revenue and Forecast, by End-Users (2021-2033)
Chapter 12. Company Profiles
12.1. Universal Health Services, Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Magellan Health Inc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. National Mentor Holdings Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Behavioral Health Network Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. North Range Behavioral Health
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Behavioral Health Services Inc.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Acadia Healthcare Co.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Seton Healthcare Family
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Beacon Health Strategies
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms